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GB virus C/hepatitis G virus (GBV-C/HGV), which 
was initially thought to be the putative agent of non- 
A-E viral hepatitis, has the same transmission route as 
hepatitis C virus (HCV).’ However, the clinical signific- 
ance is not clear. At present, GBV-C/HGV seems to be 
classified into five different genotypes corresponding to 
geographic distribution, genotype 1 being predominant 
in West Africa, genotype 2 in the USA and Europe, 
genotype 3 in Asia, genotype 4 in South East Asia, and 
genotype 5 in South Africae2 
Our aim was to determine the GBV-C/HGV RNA 
seropositivity rate among renal transplant recipients 
in Izmir and to identify the genotypes by partially 
sequencing the 5’ non-coding region (NCR), since the 
genotype distribution of GBV-C/HGV isolates in 
Turkey was not known. The region between nucleotides 
100 and 285 (based on the U44402 sequence), which 
corresponds to the region between nucleotides -239 
and -424, based on Smith’s3 definition, was chosen. 
This position seems to be appropriate both for screening 
GBV-C/HGV RNA and for determining the identified 
genotypes, since it contains both well-conserved and 
genotype-specific sequences. This method is practical 
and economical in terms of both time and cost, as 
sequencing can be performed directly on amplicons 
obtained from GBV-CYHGV RNA PCR screening 
assays. 
Serum samples from 69 renal transplant recipients 
(35 males, 34 females; age 3329) were screened for 
GBV-C/HGV RNA by PCR as described by Schlueter 
et al4 Sequences from 15 GBV-C/HGV -RNA-positive 
samples were analyzed for genotypes. An additional 
three samples obtained from two chronic hepatitis C 
cases and one chronic hepatitis B case were also 
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included for genotyping. Bidirectional nucleic acid 
sequences obtained by use of the Big Dye Terminator 
kit were analyzed on an ABI Prism 310 (PE Applied 
Biosystems, Foster City, Ca, USA). Sequences were 
multiply aligned using Clustal W (~1.8). Phylogenetic 
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Figure 1. Phylogram generated by neighbor-joining analysis 
of genetic distances in the 5’NCR (nucleotide positions between 
100 and 285) of GBV-UHGV isolates. RT, renal transplant; GE, 
gastroenterology; Gr, Greek; Pak, Pakistan; VT, Vietnamese; 
MY, Myanmarese; Ind, Indonesian; EA, East African; WA, West 
African; 5A. South African; GA, Ghana. HCV RNA-positive 
samples were RT2227, RT2275, RT2312, RT2354, RT2365, and 
RT2592. 
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trees were produced using the neighbor-joining method 
in the Treecon (1.3b) program. In addition to the repre- 
sentative sequences reported for genotypes, sequences 
reported as novel distinct phylogenetic groups/geno- 
types from South Africa and from South East Asia 
countries, with examples of some sequences from 
Greece, are included in the phylogenetic analysis. 
GBV-C/HGV RNA seropositivity was found to be 
42% among renal transplant recipients in the Renal 
Transplantation Unit of Ege University. This rate is 
significantly higher than the rate in the Turkish blood 
donor population (l-2% according to our unpublished 
data and Gtinaydm et a15). GBV-C/HGV RNA pre- 
valence was similar in the HCV RNA-positive and 
-negative patient populations (41% and 43% respec- 
tively) . 
All of our isolates grouped as type 2, as shown in 
Figure 1. Two sequences appeared as subgroup 2b, while 
the rest of the sequences appeared as 2a according to 
Smith’s; description. There was no significant clustering 
among Izmir isolates. GBV-C/HGV nucleotide sequence 
data reported in this paper have been submitted to the 
GenBank databases under accession numbers AF255076 
to AF255091. 
In conclusion, GBV-C/HGV viremia is highly 
prevalent in renal transplant recipients in this center; 
genotype 2 is the dominant type, subgroup 2a being the 
most common of the isolates in this population. 
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